Protalix BioTherapeutics
PLX
#8625
Rank
NZ$0.22 B
Marketcap
$3.11
Share price
1.15%
Change (1 day)
12.58%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -NZ$12.83 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$45.66 Million. In 2023 the company made an earning of NZ$20.78 Million, an increase over its 2022 earnings that were of -NZ$20.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$12.83 Million-161.68%
2023 NZ$20.78 M-199.05%
2022 -NZ$20.99 Million-40.38%
2021 -NZ$35.2 Million-732.31%
2020 NZ$5.56 M-130.53%
2019 -NZ$18.24 Million189.85%
2018 -NZ$6.29 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$32.74 Million-32.37%
2015 -NZ$48.4 Million10.11%
2014 -NZ$43.96 Million-7.59%
2013 -NZ$47.57 Million
2011 -NZ$55.08 Million-19.39%
2010 -NZ$68.33 Million20.87%
2009 -NZ$56.53 Million32.26%
2008 -NZ$42.74 Million-5.46%
2007 -NZ$45.21 Million
2004 -NZ$0.3 Million12.35%
2003 -NZ$0.27 Million-11.1%
2002 -NZ$0.3 Million-57.03%
2001 -NZ$0.69 Million1.03%
2000 -NZ$0.68 Million-53.22%
1999 -NZ$1.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.13 Billion 781.03%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.16 B-8,564.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.27 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.74 B-5,513.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel